Clinical Trial Update: FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing FLOT with and without HER2-targeted therapy (Herceptin/Pertuzumab) as perioperative treatment for HER-2 expressing gastric or GEJ ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Junction Cancer
• Stomach Cancer

Drugs mentioned

• FLOT
• HERCEPTIN (trastuzumab)
• Pertuzumab (pertuzumab)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Stomach Cancer, Gastroesophageal Junction Cancer | Phase 2, Phase 3 | Status: COMPLETED